ULTRALIFE CORP (ULBI)
US9038991025 - Common Stock
ULBI gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 86 industry peers in the Electrical Equipment industry. ULBI has an average financial health and profitability rating. ULBI is not valued too expensively and it also shows a decent growth rate.
1. Profitability
1.1 Basic Checks
In the past year ULBI was profitable.
In the past year ULBI had a positive cash flow from operations.
In multiple years ULBI reported negative net income over the last 5 years.
In multiple years ULBI reported negative operating cash flow during the last 5 years.
1.2 Ratios
Looking at the Return On Assets, with a value of 5.78%, ULBI is in the better half of the industry, outperforming 79.76% of the companies in the same industry.
The Return On Equity of ULBI (8.10%) is better than 72.62% of its industry peers.
ULBI has a better Return On Invested Capital (6.76%) than 72.62% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 5.78% | ||
| ROE | 8.1% | ||
| ROIC | 6.76% |
ROA(3y)1.28%
ROA(5y)2.24%
ROE(3y)1.83%
ROE(5y)2.94%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
ULBI has a better Profit Margin (6.19%) than 78.57% of its industry peers.
In the last couple of years the Profit Margin of ULBI has declined.
The Operating Margin of ULBI (8.02%) is better than 70.24% of its industry peers.
ULBI's Operating Margin has declined in the last couple of years.
ULBI has a Gross Margin (25.63%) which is in line with its industry peers.
ULBI's Gross Margin has declined in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 8.02% | ||
| PM (TTM) | 6.19% | ||
| GM | 25.63% |
OM growth 3Y4.11%
OM growth 5Y-4.63%
PM growth 3Y-2.06%
PM growth 5Y-30.78%
GM growth 3Y-3.05%
GM growth 5Y-3.39%
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), ULBI is destroying value.
The number of shares outstanding for ULBI has been increased compared to 1 year ago.
The number of shares outstanding for ULBI has been increased compared to 5 years ago.
ULBI has a worse debt/assets ratio than last year.
2.2 Solvency
ULBI has an Altman-Z score of 3.89. This indicates that ULBI is financially healthy and has little risk of bankruptcy at the moment.
ULBI has a Altman-Z score of 3.89. This is in the better half of the industry: ULBI outperforms 76.19% of its industry peers.
The Debt to FCF ratio of ULBI is 31.66, which is on the high side as it means it would take ULBI, 31.66 years of fcf income to pay off all of its debts.
Looking at the Debt to FCF ratio, with a value of 31.66, ULBI is in the better half of the industry, outperforming 70.24% of the companies in the same industry.
A Debt/Equity ratio of 0.18 indicates that ULBI is not too dependend on debt financing.
Looking at the Debt to Equity ratio, with a value of 0.18, ULBI is in line with its industry, outperforming 55.95% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.18 | ||
| Debt/FCF | 31.66 | ||
| Altman-Z | 3.89 |
ROIC/WACC0.63
WACC10.7%
2.3 Liquidity
ULBI has a Current Ratio of 4.03. This indicates that ULBI is financially healthy and has no problem in meeting its short term obligations.
ULBI has a better Current ratio (4.03) than 86.90% of its industry peers.
A Quick Ratio of 2.16 indicates that ULBI has no problem at all paying its short term obligations.
ULBI has a better Quick ratio (2.16) than 79.76% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 4.03 | ||
| Quick Ratio | 2.16 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an impressive 1460.00% over the past year.
Measured over the past years, ULBI shows a very negative growth in Earnings Per Share. The EPS has been decreasing by -21.94% on average per year.
The Revenue has grown by 26.44% in the past year. This is a very strong growth!
Measured over the past years, ULBI shows a quite strong growth in Revenue. The Revenue has been growing by 12.71% on average per year.
EPS 1Y (TTM)1460%
EPS 3Y10.36%
EPS 5Y-21.94%
EPS growth Q2Q2200%
Revenue 1Y (TTM)26.44%
Revenue growth 3Y13.78%
Revenue growth 5Y12.71%
Revenue growth Q2Q31.35%
3.2 Future
No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y25.68%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year10.71%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
3.3 Evolution
No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
4. Valuation
4.1 Price/Earnings Ratio
With a Price/Earnings ratio of 16.99, ULBI is valued correctly.
Compared to the rest of the industry, the Price/Earnings ratio of ULBI indicates a rather cheap valuation: ULBI is cheaper than 83.33% of the companies listed in the same industry.
ULBI is valuated rather cheaply when we compare the Price/Earnings ratio to 28.02, which is the current average of the S&P500 Index.
The Price/Forward Earnings ratio is 18.83, which indicates a rather expensive current valuation of ULBI.
Based on the Price/Forward Earnings ratio, ULBI is valued a bit cheaper than 79.76% of the companies in the same industry.
The average S&P500 Price/Forward Earnings ratio is at 20.58. ULBI is around the same levels.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 16.99 | ||
| Fwd PE | 18.83 |
4.2 Price Multiples
Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of ULBI indicates a somewhat cheap valuation: ULBI is cheaper than 79.76% of the companies listed in the same industry.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of ULBI indicates a somewhat cheap valuation: ULBI is cheaper than 67.86% of the companies listed in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 274.85 | ||
| EV/EBITDA | 13.38 |
4.3 Compensation for Growth
The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
PEG (NY)0.66
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A
5. Dividend
5.1 Amount
No dividends for ULBI!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
ULTRALIFE CORP
NASDAQ:ULBI (5/6/2024, 7:00:02 PM)
After market: 13.35 +0.1 (+0.75%)13.25
+0.7 (+5.58%)
Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryElectrical Equipment
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap218.23M
Analysts
Price Target
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 16.99 | ||
| Fwd PE | 18.83 | ||
| P/S | |||
| P/FCF | |||
| P/OCF | |||
| P/B | |||
| P/tB | |||
| EV/EBITDA |
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)0.66
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 5.78% | ||
| ROE | 8.1% | ||
| ROCE | |||
| ROIC | |||
| ROICexc | |||
| ROICexgc | |||
| OM | 8.02% | ||
| PM (TTM) | 6.19% | ||
| GM | 25.63% | ||
| FCFM |
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.93
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.18 | ||
| Debt/FCF | |||
| Debt/EBITDA | |||
| Cap/Depr | |||
| Cap/Sales | |||
| Interest Coverage | |||
| Cash Conversion | |||
| Profit Quality | |||
| Current Ratio | 4.03 | ||
| Quick Ratio | 2.16 | ||
| Altman-Z |
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
Growth
EPS 1Y (TTM)1460%
EPS 3Y10.36%
EPS 5Y
EPS growth Q2Q
EPS Next Y25.68%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)26.44%
Revenue growth 3Y13.78%
Revenue growth 5Y
Revenue growth Q2Q
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y